Skip to main content
. Author manuscript; available in PMC: 2023 Nov 27.
Published in final edited form as: Sci Transl Med. 2023 Jun 14;15(700):eabo2984. doi: 10.1126/scitranslmed.abo2984

Table 1.

Participant demographics at the time of stool sampling stratified by AD preclinical status.

Healthy Preclinical AD P
Number 115 49
Age in years, mean (SD) 77.02 (5.80) 78.96 (4.51) 0.039
Sex (%) Male 49 (42.6) 24 (49.0) 0.562
Years of education, mean (SD) 16.42 (2.26) 16.69 (2.53) 0.49
Race(%) Black 18 (15.7) 1 (2.0) 0.034
White 96 (83.5) 48 (98.0)
Other 1 (0.9) 0 (0.0)
Body mass index, mean (SD) 28.81 (5.03) 26.73 (5.19) 0.018
APOE4 (%) e4+ 26 (22.6) 23 (46.9) 0.003
Active depression (%) 3 (2.6) 1 (2.0) 1
Alcohol abuse (%) 7 (6.1) 1 (2.0) 0.481
Autoimmune disorder (%) 11 (9.6) 5 (10.2) 1
Cancer(%) 6 (5.2) 2 (4.1) 1
Cardiovascular disease (%) 14 (12.2) 6 (12.2) 1
Diabetes (%) 22 (19.1) 1 (2.0) 0.008
Hypercholesterolemia (%) 69 (60.0) 25 (51.0) 0.373
Hypertension (%) 74 (64.3) 23 (46.9) 0.057
Liver disease (%) 7 (6.1) 3 (6.1) 1
Thyroid disease (%) 21 (18.3) 10 (20.4) 0.917
Tobacco use (past or present) (%) 51 (44.3) 24 (49.0) 0.709

P, Student’s t test (continuous variables) or chi-square test (categorical variables).

Rheumatoid arthritis, lupus, etc.